Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of an Artificial Intelligence Platform (DERM) on the Healthcare Resource Utilisation (HRU) Needed to Diagnose Skin Cancer When Used as Part of a United Kingdom-based Teledermatology Service

NCT04123678 is registered in ClinicalTrials.gov with Skin Analytics Limited as lead sponsor.

NCT NCT04123678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04123678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of an Artificial Intelligence Platform (DERM) on the Healthcare Resource Utilisation (HRU) Needed to Diagnose Skin Cancer When Used as Part of a United Kingdom-based Teledermatology Service
Lead sponsor
Skin Analytics Limited
Phase
Observational
Overall status
Completed
Start date
February 26, 2020
Completion date
August 6, 2021
Enrollment
700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, non-melanoma skin cancer